ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 38 filers reported holding ACER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,786 | -10.6% | 53,035 | 0.0% | 0.00% | – |
| Q2 2023 | $48,973 | +17.6% | 53,035 | -3.4% | 0.00% | – |
| Q1 2023 | $41,661 | -84.9% | 54,925 | -50.0% | 0.00% | – |
| Q4 2022 | $275,724 | +884.7% | 109,850 | +443.1% | 0.00% | – |
| Q3 2022 | $28,000 | -6.7% | 20,225 | -13.8% | 0.00% | – |
| Q2 2022 | $30,000 | -59.5% | 23,465 | -8.2% | 0.00% | – |
| Q1 2022 | $74,000 | +29.8% | 25,565 | +2.4% | 0.00% | – |
| Q4 2021 | $57,000 | -10.9% | 24,965 | 0.0% | 0.00% | – |
| Q3 2021 | $64,000 | -9.9% | 24,965 | 0.0% | 0.00% | – |
| Q2 2021 | $71,000 | +91.9% | 24,965 | +94.3% | 0.00% | – |
| Q3 2020 | $37,000 | -37.3% | 12,849 | -25.6% | 0.00% | – |
| Q2 2020 | $59,000 | -78.3% | 17,259 | -87.4% | 0.00% | – |
| Q1 2020 | $272,000 | -39.1% | 136,735 | +22.5% | 0.00% | – |
| Q4 2019 | $447,000 | -6.9% | 111,579 | -25.8% | 0.00% | – |
| Q3 2019 | $480,000 | +22.1% | 150,466 | +49.4% | 0.00% | – |
| Q2 2019 | $393,000 | – | 100,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 143,000 | $2,877,000 | 2.19% |
| Vivo Capital, LLC | 579,051 | $11,651,000 | 1.49% |
| Nantahala Capital Management | 903,455 | $18,178,000 | 0.56% |
| HEARTLAND ADVISORS INC | 220,000 | $4,426,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 388,712 | $7,821,000 | 0.34% |
| Avoro Capital Advisors LLC | 150,000 | $3,018,000 | 0.18% |
| Monashee Investment Management LLC | 11,364 | $229,000 | 0.16% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 125,000 | $2,515,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 20,000 | $402,000 | 0.10% |
| 683 Capital Management, LLC | 19,367 | $390,000 | 0.02% |